References
Galor A, Perez VL, Hammel JP, et al. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation. Ophthalmol 2003;113:2317–2323.
Lim LL, Fraunfelder FW, Rosenbaum JT. Do tumor necrosis factor inhibitors cause uveitis? A registry-based study. Arthritis Rheum 2007;56:3248–3252.
Hashkes PJ, Shajrawi I. Sarcoid-related uveitis occurring during etanercept therapy. Clin Exp Rheumatol 2003;21:645–646.
Prasse A, Georges CG, Biller H, et al. Th1 cytokine pattern in sarcoidosis is expressed by bronchoalveolar CD4+ and CD8+ T cells. Clin Exp Immunol 2000;122:241–248.
Sieper J, Van den Brande J. Diverse effects of infliximab and etanercept on T lymphocytes. Semin Arthritis Rheum 2005;34:23–27.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Suzuki, J., Goto, H. Uveitis associated with sarcoidosis exacerbated by etanercept therapy. Jpn J Ophthalmol 53, 439–440 (2009). https://doi.org/10.1007/s10384-009-0691-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10384-009-0691-6